Compounds for treatment of cancer
US10865196B2 · kind B2 · utility
0Cited by
14References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 16, 2018 |
| Grant date | Dec 15, 2020 |
| Priority date | — |
| Expiry date | Jan 16, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a compound of formula XXII and a compound of formula 17ya, which are defined as anywhere in the specification, to a composition comprising the same, and to a method of using thereof in the treatment of various forms of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.